RNA-based therapeutics for neurological diseases

RNA-based therapeutics have entered the mainstream with seemingly limitless possibilities to treat all categories of neurological disease. Here, common RNA-based drug modalities such as antisense oligonucleotides, small interfering RNAs, RNA aptamers, RNA-based vaccines and mRNA drugs are reviewed h...

Descripción completa

Detalles Bibliográficos
Autor principal: Anthony, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786337/
https://www.ncbi.nlm.nih.gov/pubmed/35067193
http://dx.doi.org/10.1080/15476286.2021.2021650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786337/
https://www.ncbi.nlm.nih.gov/pubmed/35067193
http://dx.doi.org/10.1080/15476286.2021.2021650

Ejemplares similares